 Canalevia would be first and only FDA-approved plant-based medicine for dogs that suffer from diarrhea during chemotherapy Canalevia will be available by fourth quarter 2021, if conditionally approved SAN FRANCISCO, CA ACCESSWIRE May 18, 2021 Jaguar Health, Inc. NASDAQ:JAGX Jaguar or the Company today provided updates regarding the development program for the Companys oral plant-based drug candidate CanaleviaTM crofelemer delayed-release tablets to treat chemotherapy-induced diarrhea CID in dogs and exercise-induced diarrhea EID in dogs. There currently is no FDA-approved anti-secretory prescription product to manage these types of debilitating diarrhea in dogs. 